Close

MVP acquires Avita Medical’s Australian Respiratory Business

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Medical Developments International Limited is delighted to announce that it has signed an agreement to acquire the respiratory business of Avita Medical Limited (ASX: AVH). Avita’s respiratory business includes the Breath-A-Tech branded range of products, which is the leading brand of asthma space chambers in the Australian pharmacy and hospital markets.

The total consideration is circa $2.64m comprising $2.2m cash plus (at MVP’s option) either 125,000 new MVP shares escrowed for 6 months (adjusted based on the 5-day VWAP prior to completion) or $0.44m of cash.

Latest stories